Neurimmune Holding AG - Company Review
Neurimmune Holding AG - Company ReviewSummary
Neurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human disorders with a focus on neurodegenerative disorders. It provides treatment and prevention of human disorders with unmet medical needs. Neurimmune by utilizing its reverse translational medicine technology platform develops human antibodies as therapeutics. The company’s human antibodies are used as drug candidates in the treatment of diseases such as Alzheimer's disease, Parkinson's disease and other central nervous system disorders, tauopathies and amyotrophic lateral sclerosis. It operates through research universities and other biotechnology companies to develop and commercialize novel treatments for Alzheimer’s disease. The company provides programs for transthyretin amyloidosis, type-2 diabetes and amyotrophic lateral sclerosis. Neurimmune is headquartered in Zurich, Switzerland.
This comprehensive company report of Neurimmune Holding AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.